Minimal Residual Disease as a Primary Endpoint in Multiple Myeloma: Implications for Clinical Trials and Everyday Clinical Practice
Clinical endpoint
Endpoint Determination
Minimal Residual Disease
Clinical Practice
Primary (astronomy)
DOI:
10.1182/hem.v22.1.202511
Publication Date:
2025-01-14T20:34:58Z
AUTHORS (3)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (20)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....